Non-Antibody Products — page 175 of 187
Non-Antibody Products
Page 175 of 187
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Recombinant Bat coronavirus 133/2005 Spike glycoprotein (S), partial | coronavirus 133 / 2005 (BtCoV) (BtCoV/133 / 2005). Targ… | 20ug, 100ug, 1mg | RPC27965 |
 BIOMATIK |
More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | induced by MERS-CoV in Vero cells at 10 µM | 1 g | 39119-1 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| PAMAM Dendrimer G2.0 Succinamic Acid (water solution) | induced by MERS-CoV in Vero cells at 10 µM | 500 mg | 39119-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| UBE2G1 shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-93745-V |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| BIOTIN-PEG4-SBP1(spike-binding peptide 1) | SARS-CoV-2 spike protein. SBP1 specifically binds SARS-… | 5 mg | orb654591 |
 BIORBYT LTD. |
More Info |
| P504S shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-92063-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| IC-8 | formation of lipid nanoparticles (LNPs). Immunization with severe acute r… | 100 mg, 25 mg | orb1785882 |
BIORBYT LTD. |
More Info |
| Plitidepsin | inflammation in the K18-hACE2 mouse model of SARS-CoV-<… | 1 mg | 34053-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Plitidepsin | inflammation in the K18-hACE2 mouse model of SARS-CoV-<… | 500 µg | 34053-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
| ACSVL1 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-140837-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| TSCOT shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-154712-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| CD8-alpha shRNA (h2) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-35028-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| COL11A2 shRNA (mouse) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-142459-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| HscB shRNA (human) Lentiviral Particles | 10 µM, 50-100 transfections | 200 µl | sc-75306-V |
SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 10 mg | 14128-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 25 mg | 14128-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 5 mg | 14128-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Fludarabine | inhibitor of SARS-CoV-2 RdRp (EC50 = 1.06 µM); co… | 50 mg | 14128-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 10 mg | 33114-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 100 mg | 33114-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 5 mg | 33114-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Efonidipine | infarction induced by ligation of the left coronary artery at 200 mg / kg… | 50 mg | 33114-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 10 mg | 13692-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 100 mg | 13692-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Nitazoxanide | against M. tuberculosis and M. bovis (MIC = 16 µg / ml for both); i… | 250 mg | 13692-250 |
CAYMAN CHEMICAL COMPANY |
More Info |